Delivery Order SPE2DB22D2214-SPE2DB24FS5MP
Award Date
6/21/24
Potential Completion Date
6/24/24
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $5,145.40 firm fixed-price delivery order is for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat enlarged prostate. The contract has an ultimate completion date of May 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,583.25 firm fixed-price delivery order is for the supply of Tamsulosin HCl 0.4 mg capsules, a medication used to treat an enlarged prostate. The contract has a completion date of November 8, 2024 and was awarded on November 7, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,773.12, is a Delivery Order for the supply of 1,000 capsules of Tamsulosin HCl 0.4 mg, a medication used to treat enlarged prostate. The contract has an ultimate completion date of February 20, 2025 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,874.12 firm fixed-price delivery order is for the supply of 1,000 capsules of Tamsulosin HCl 0.4 mg, a medication used to treat enlarged prostate. The contract has an ultimate completion date of June 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,530,476 units of Tamsulosin HCl 0.4 mg capsules, a medication used to treat the symptoms of an enlarged prostate. The contract has a ceiling value of $6,483.58 and a completion date of May 8, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation,...
This federal contract award, valued at $1,410.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat enlarged prostate. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,080.54 firm fixed-price delivery order is for the supply of 1,000 bottles of Tamsulosin HCl 0.4 mg capsules, a medication used to treat symptoms of an enlarged prostate. The contract has a period of performance through March 5, 2024 and is not associated with any set-aside designations. AmerisourceBergen holds...
This federal contract award, valued at $3,836.76, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,925,451 units of Tamsulosin HCL 0.4 mg capsules, a medication used to treat an enlarged prostate. The contract has a period of performance through March 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,775.78 Firm Fixed Price Delivery Order is for the supply of 1,000 capsules of Tamsulosin HCl 0.4 mg, a medication used to treat benign prostatic hyperplasia. The contract has an ultimate completion date of April 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $1,423.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,178,585 units of Tamsulosin HCl 0.4 mg capsules and has an ultimate completion date of October 23, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...